Patent · US Active

Branched oligonucleotides

US10799591B2 · kind B2 · utility

12Cited by
36References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 22, 2019
Grant dateOct 13, 2020
Priority date—
Expiry dateApr 22, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are branched oligonucleotides exhibiting efficient and specific tissue distribution, cellular uptake, minimum immune response and off-target effects, without formulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.